Barclays raised the firm’s price target on Clorox (CLX) to $139 from $137 and keeps an Underweight rating on the shares. The firm says the earnings report “felt similar to previous quarters in many regards.”
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox CEO: We entered the fiscal year with strong momentum
- Clorox Company Reports Strong Q1 2025 Financial Results
- Closing Bell Movers: Microsoft, Meta both down about 3% despite earnings beats
- Clorox Sees Strong Q1 Growth Post-Cyberattack Recovery
- Clorox reports Q1 adjusted EPS $1.86, consensus $1.39